A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : p-AKT

Search Conditions:
Search Keyword : p-AKT
Search Method : Exact match.
Research Area:

Hit abbr.: 3 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: p-AKT
Appearance Frequency: 439 time(s)
Long forms: 19

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
phosphorylated AKT
(265 times)
(92 times)
PI3K (49 times)
EGFR (19 times)
p-mTOR (14 times)
2004 Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor.
(69 times)
(28 times)
PI3K (14 times)
p-mTOR (8 times)
mTOR (7 times)
2004 Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
phospho-protein kinase B
(43 times)
(7 times)
P-mTOR (11 times)
PI3K (9 times)
Bcl-2 (5 times)
2008 [Effects of ischemia postconditioning on ischemia-reperfusion injury and reperfusion injury salvage kinase signal transduction pathways in isolated mouse hearts].
phosphorylation of AKT
(32 times)
(8 times)
PI3K (7 times)
ER (3 times)
COPD (2 times)
2009 Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
phosphorylated serine/threonine kinase
(11 times)
(3 times)
PI3K (4 times)
p-PI3K (3 times)
NF-kappaB (2 times)
2008 Increased pancreatic islet mass is accompanied by activation of the insulin receptor substrate-2/serine-threonine kinase pathway and augmented cyclin D2 protein levels in insulin-resistant rats.
(4 times)
(2 times)
AKT (1 time)
CAM (1 time)
CAT (1 time)
2016 MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma.
p-protein kinase B
(2 times)
(1 time)
CCK-8 (1 time)
DEX (1 time)
EGFR (1 time)
2019 Interaction between epidermal growth factor receptor and interleukin-6 receptor in NSCLC progression.
phosphorylated ATP-dependent tyrosine kinase
(2 times)
(1 time)
AR_H460 (1 time)
Bcl-2 (1 time)
Cdc42 (1 time)
2016 Renieramycin M Sensitizes Anoikis-resistant H460 Lung Cancer Cells to Anoikis.
patterns, but there was hyperactivation of AKT
(1 time)
(1 time)
--- 2013 Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
10  pGz increased Akt phosphorylation
(1 time)
(1 time)
--- 2009 In vivo upregulation of nitric oxide synthases in healthy rats.
11  phosphatized AKT
(1 time)
(1 time)
DFS (1 time)
EGFR (1 time)
ER (1 time)
2007 [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
12  phospho-Ser473-AKT
(1 time)
(1 time)
p-Src (1 time)
2017 Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
13  phosphorylated AKT kinase
(1 time)
(1 time)
IR (1 time)
PCNA (1 time)
2006 Radiation-induced molecular changes in rat mammary tissue: possible implications for radiation-induced carcinogenesis.
14  phosphorylation status of AKT
(1 time)
Cell Biology
(1 time)
CXCR4 (1 time)
DFO (1 time)
HIF-1alpha (1 time)
2018 Deferoxamine promotes mesenchymal stem cell homing in noise-induced injured cochlea through PI3K/AKT pathway.
15  protein and a 21-53% drop in active AKT kinase
(1 time)
Cell Biology
(1 time)
--- 2015 MicroRNA-126 suppresses proliferation of undifferentiated (BRAF(V600E) and BRAF(WT)) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathway.
16  protein kinase B phosphorylation
(1 time)
(1 time)
PIC (1 time)
PR (1 time)
TRAF2 (1 time)
2013 Blockage of progesterone receptor effectively protects pancreatic islet beta cell viability.
17  protein-serine-threonine kinase
(1 time)
Stem Cells
(1 time)
CSC (1 time)
HIF-2alpha (1 time)
p-mTOR (1 time)
2020 HIF-2alpha regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling.
18  proteins abundances of AKT
(1 time)
Cell Biology
(1 time)
ADSCs (1 time)
mRNA (1 time)
qRT-PCR (1 time)
2020 The potential role of stromal cell-derived factor-1alpha/CXCR4/CXCR7 axis in adipose-derived mesenchymal stem cells.
19  PTEN and phosphorylation of AKT
(1 time)
Molecular Biology
(1 time)
3-BrPA (1 time)
NSCLC (1 time)
TRIM59 (1 time)
2020 TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.